Moss Genomics Inc. — Investor Relations & Filings
Moss Genomics Inc. is a biotechnology company specializing in genomics and microbiome research, dedicated to developing advanced genetic insights and personalized health solutions. The company's core offering is a blockchain-based platform designed for the private, secure storage and monetization of individual genomic data. Recent corporate strategy has emphasized significant integration with digital assets, positioning the company as a hybrid entity. This strategy includes substantial investments in Ethereum (ETH) and participation in cryptocurrency mining operations, such as Bitcoin Cash (BCH), alongside its consumer genomics initiatives.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2026-03-02 | English | |
| Interim MD&A - English.pdf | 2026-03-02 | English | |
| Interim financial statements/report – English.pdf | 2026-03-02 | English | |
| News release - English.pdf | 2026-01-05 | English | |
| 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2025-12-02 | English | |
| Interim MD&A - English.pdf | 2025-12-01 | English |
Browse filings by year
5 yearsMarket data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
IMAGION BIOSYSTEMS LIMITED
Develops nanoparticle-based imaging for non-invasive cancer…
|
IBX | AU | Professional, scientific and te… |
|
IMCB PJSC
Biotechnology company specializing in personal stem cell ba…
|
GEMA | RU | Professional, scientific and te… |
|
Immuneering Corp
Clinical-stage oncology company developing medicines using …
|
IMRX | US | Professional, scientific and te… |
|
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Clinical-stage biotech developing dual-approach immuno-onco…
|
1541 | HK | Professional, scientific and te… |
|
IMMUNIC, INC.
Develops oral small molecule therapies for chronic inflamma…
|
IMUX | US | Professional, scientific and te… |
|
Immunovant, Inc.
Clinical-stage immunology company developing anti-FcRn anti…
|
IMVT | US | Professional, scientific and te… |
|
IMMUPHARMA PLC
Specialty biopharmaceutical company developing peptide-base…
|
IMM | GB | Professional, scientific and te… |
|
IMMUTEP LIMITED
Develops LAG-3 targeting immunotherapies for cancer and aut…
|
IMM | AU | Professional, scientific and te… |
|
IMMUTEP Ltd
Biotechnology company developing LAG-3 immunotherapies for …
|
IMMP | US | Professional, scientific and te… |
|
IMPACT BIOMEDICAL INC.
Develops biopharmaceutical products and technologies to pro…
|
IBO | US | Professional, scientific and te… |
Moss Genomics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/48378/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=48378 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=48378 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=48378 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 48378}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Moss Genomics Inc. (id: 48378)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.